TH168006B - A solbenzene derivative and its crystal form. - Google Patents

A solbenzene derivative and its crystal form.

Info

Publication number
TH168006B
TH168006B TH1701000507A TH1701000507A TH168006B TH 168006 B TH168006 B TH 168006B TH 1701000507 A TH1701000507 A TH 1701000507A TH 1701000507 A TH1701000507 A TH 1701000507A TH 168006 B TH168006 B TH 168006B
Authority
TH
Thailand
Prior art keywords
solbenzene
derivative
crystal form
crystals
dimethylpropoxi
Prior art date
Application number
TH1701000507A
Other languages
Thai (th)
Other versions
TH168006A (en
Original Assignee
เทจิน ฟาร์มา ลิมิเต็ด
Filing date
Publication date
Application filed by เทจิน ฟาร์มา ลิมิเต็ด filed Critical เทจิน ฟาร์มา ลิมิเต็ด
Publication of TH168006A publication Critical patent/TH168006A/en
Publication of TH168006B publication Critical patent/TH168006B/en

Links

Abstract

ได้จัดให้มี ผลึกของ 2-[4-(2,2-ไดเมธิลโพรพอกซี)-3-(1H-1,2,3,4-เตตระโซล-1-อิล)ฟีนิล]- 4-เมธิล-1,3-ไธอะโซล-5-คาร์บอกซิลิก แอสิด ซึ่งเป็นประโยชน์ในฐานะเป็นสารบำบัดหรือสารป้อง กันสำหรับโรคเกาต์, ภาวะกรดยูริกในเลือดสูง และสิ่งที่คล้ายกันนั้น The crystals of 2- (4- (2,2-dimethylpropoxi) -3- (1H-1,2,3,4-tetrazol-1-il) phenyl were provided. ] - 4-methyl-1,3-thiazole-5-carboxylic acid, which is useful as a therapeutic agent or a cupping agent. For gout, high blood uric acid. And similar things

Claims (1)

1. ผลึกของ 2-[4-(2,2-ไดเมธิลโพรพอกซี)-3-(1H-1,2,3,4-เตตระโซล-1-อิล)ฟีนิล]-4-เมธิล- 1,3-ไธอะโซล-5-คาร์บอกซีลิก แอสิด 2. ผลึกตามข้อถือสิทธิที่, 1, ที่ซึ่ง ผลึกมีรูปผลึก A 3. ผลึกตามข้อถือสิทธิที่ 2, ที่ซึ่ง ผลึกมีพีคลักษณะเฉพาะที่มุมเลี้ยวเบนของ 2(สูตร) = 7.2 ํ, 11.3 ํ 15.9 ํ 17.9 ํ, 20.8 ํ, 22.3 ํ, 23.1 ํ, 23.8 ํ, 241. Crystals of 2- (4- (2,2-dimethylpropoxi) -3- (1H-1,2,3,4-tetrazol-1-il) phenyl] - 4-methyl-1,3-thiazole-5-carboxylic acid 2. crystals according to claim, 1, where crystals have the form of A 3. crystals according to claim At 2, where the crystal has a characteristic peak at the diffraction angle of 2 (formula) = 7.2 ํ, 11.3 ํ 15.9 ํ, 17.9 ํ, 20.8 ํ, 22.3 ํ, 23.1 ํ, 23.8 ํ, 24
TH1701000507A 2015-07-29 A solbenzene derivative and its crystal form. TH168006B (en)

Publications (2)

Publication Number Publication Date
TH168006A TH168006A (en) 2017-09-21
TH168006B true TH168006B (en) 2017-09-21

Family

ID=

Similar Documents

Publication Publication Date Title
AR116394A2 (en) N- [5- (AMINOSULFONYL) -4-METHYL-1,3-THIAZOL-2-IL] -N-METHYL-2- [4- (2-PYRIDINYL) PHENYL] ACETAMIDE MONOHYDRATE MESILATE
JOP20190182B1 (en) N-[4-fluoro-5-[[(2s,4s)-2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]-1-piperidyl]methyl]thiazol-2-yl]acetamide as oga inhibitor
EA202191466A1 (en) METHODS FOR THE TREATMENT OF CHOLESTATIC AND FIBROTIC DISEASES
EA201270676A1 (en) POLYMORPHIC, CRYSTAL AND MESOPHASE FORMS OF 2- (5-BROM-4- (4-CYCLOPROPYLNAFTALINYL-1-IL) -4N-1,2,4-TRIAZOL-3-ILTIO) SODIUM ACETATE AND THEIR USE
EA201691401A1 (en) INDASOLIC COMPOUNDS AS IRAK4 INHIBITORS
EA201370150A1 (en) POLYMORPHIC FORMS 2- (5-BROM-4- (4-CYCLOPROPILNAFTALIN-1-IL) -4H-1,2,4-TRIAZOL-3-ILTIO) ACETIC ACID AND THEIR APPLICATION
EA201691997A1 (en) 2,4-TIAZOLINIDON DERIVATIVES IN THE TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM
EA202192320A1 (en) CRYSTALLINE FORM OF 1- (1-OXO-1,2-DIHYDROISOCHINOLIN-5-YL) -5- (TRIFLUOROMETHYL) -N- [2- (TRIFLUOROMETHYL) PYRIDIN-4-YL] -1H-PYRAZOL-4-CARBOXAMIDE MONOHYDRATE
PE20180204A1 (en) PROCEDURE FOR THE PREPARATION OF 2-4- [2 - ([2- (4- (CHLOROPHENIL) -1,3-THIAZOL-4-IL] METHYLSULFANIL) -3,5-DICIANE-6- (PYRROLIDIN-1-IL ) PYRIDINE-4-IL] PHENOXYETHYL-L-ALANIL-L-ALANINATE-MONOHYDROCHLORIDE
WO2017094031A3 (en) Novel process for preparation of apremilast
TH168006B (en) A solbenzene derivative and its crystal form.
PH12017500123B1 (en) Crystal of azole benzene derivative
PE20171349A1 (en) BACE1 INHIBITORS
TH168006A (en) A solbenzene derivative and its crystal form.
PT2943488T (en) Meglumine salt forms of 2-((1 r,4r)-4-(4-(5-(benzoxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl) acetic acid and their use as dgat1 inhibitors
TH168005B (en) A solbenzene derivative and its crystal form.
WO2019152546A3 (en) Salt forms of organic compound
PH12017500124A1 (en) Azole benzene derivative and crystalline form thereof
TH168005A (en) A solbenzene derivative and its crystal form.
MX2017016042A (en) Polymorphs of a pges-1 inhibiting triazolone compound.
IL287230A (en) Process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives
IL287228A (en) Process for the production of substituted 2-[2-(phenyl) ethylamino]alkaneamide derivatives
RU2020127993A (en) THERAPEUTIC FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
RU2016138700A (en) Blood clot inhibitor
WO2014123456A3 (en) Alkyl [(s)-1-((s)-2-{5-[4-(4-{2-[(s)-1-((s)-2-methoxycarbonylamino-3-methyl-butyryl)-pyrrolidine-2-yl]-3h-imidazole-4-yl}-buta-1,3-dienyl)-phenyl]-1h-imidazole-2-yl}-pyrrolidine-1-carbonyl)-2-methyl-propyl]-carbamate naphthalene-1,5-disulfonate for the treatment of viral diseases